Skip to main content

and
  1. Article

    Open Access

    Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts

    To assess whether quantitative assessment of symptom reduction is a better outcome parameter than cyst volume reduction for treatment success in patients treated by aspiration sclerotherapy.

    Myrte K. Neijenhuis, Titus F. M. Wijnands, Wietske Kievit in European Radiology (2019)

  2. Article

    Open Access

    Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial

    We tested whether complementary use of the somatostatin analogue pasireotide would augment efficacy of aspiration sclerotherapy of hepatic cysts.

    Titus F. M. Wijnands, Tom J. G. Gevers, Marten A. Lantinga in European Radiology (2018)

  3. Article

    Open Access

    Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data

    To identify predictive variables of treatment response following aspiration sclerotherapy of large symptomatic hepatic cysts.

    Titus F. M. Wijnands, Maxime Ronot, Tom J. G. Gevers, Julie Benzimra in European Radiology (2017)